Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.

被引：0
|
作者：
Canzanello, VJ [1 ]
Schwartz, LL [1 ]
Taler, SJ [1 ]
Textor, SC [1 ]
Atwood, G [1 ]
Porayko, MK [1 ]
Wiesner, RH [1 ]
Krom, RAF [1 ]
机构：
[1] MAYO CLIN,ROCHESTER,MN
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1443 / 1443
页数：1
相关论文
共 50 条
  • [31] Cardiovascular Risk Factors after Conversion from Cyclosporine to Tacrolimus in Children after Liver Transplantation
    Czubkowski, Piotr
    Wierzbicka, Aldona
    Socha, Piotr
    Jankowska, Irena
    Pawlowska, Joanna
    [J]. ANNALS OF TRANSPLANTATION, 2014, 19
  • [32] CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK 506-BASED IMMUNOSUPPRESSION - BENEFITS AND PITFALLS
    FUNG, JJ
    TODO, S
    TZAKIS, A
    DEMETRIS, A
    JAIN, A
    ABUELMAGD, K
    ALESSIANI, M
    STARZL, TE
    [J]. TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 14 - 21
  • [33] Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients
    Mariano Ferraresso
    Luciana Ghio
    Alberto Edefonti
    Rosanna Garavaglia
    Luisa Berardinelli
    [J]. Pediatric Nephrology, 2002, 17 : 664 - 667
  • [34] Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients
    Ferraresso, M
    Ghio, L
    Edefonti, A
    Garavaglia, R
    Berardinelli, L
    [J]. PEDIATRIC NEPHROLOGY, 2002, 17 (08) : 664 - 667
  • [35] Validation of cardiovascular risk scores in liver transplant recipients.
    Guckelberger, O
    Mutzke, F
    Langrehr, JM
    Klupp, J
    Neumann, UP
    Glanemann, M
    Neuhaus, R
    Neuhaus, P
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : C30 - C30
  • [36] Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation
    Lipson, DA
    Palevsky, HI
    Kotloff, RM
    Edelman, J
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1505 - 1507
  • [37] Effect of gut metabolism on tacrolimus (FK-506) bioavailability in renal transplant recipients
    Tuteja, S
    Alloway, RR
    Johnson, JA
    Gaber, AO
    [J]. TRANSPLANTATION, 1999, 67 (07) : S159 - S159
  • [38] Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients - Discussion
    Lund, DP
    McKee, M
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (07) : 975 - 975
  • [39] THE TREATMENT OF INTRACTABLE REJECTION WITH TACROLIMUS (FK506) IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    MCDIARMID, SV
    WALLACE, P
    VARGAS, J
    AMENT, ME
    BUSUTTIL, RW
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 20 (03): : 291 - 299
  • [40] Lack of interaction between tacrolimus (FK506) and methotrexate (MTX) in bone marrow transplant (BMT) recipients.
    Wingard, JR
    Nash, RA
    Ratanatharathorn, V
    Fay, JW
    Klein, JL
    Przepiorka, D
    Devine, SM
    Fitzsimmons, WE
    [J]. BLOOD, 1995, 86 (10) : 1570 - 1570
12345